According to the current analysis
of Reports and Data, the global Immunohematology
market was valued at USD 1.66 billion in 2018 and is expected to reach
USD 2.45 billion by the year 2026, growing at a CAGR of 5.0%.
Immunohematology is a branch of “Hematology,” which facilitates the screening
of donor blood for antigens, Rh factor, and other blood components such as
white blood cells. Commonly known as “Blood Banking,” it prepares blood
components for transfusion and helps in reducing transfusion-related diseases
such as HIV and thalassemia.
Immunohematology enables safe
blood transfusion and transplantation of hematopoietic tissue, as well as
prevent the undesired immune-related complications, transplantation, and
pregnancy-related issues. High incidence of hematological diseases, increasing
demand for platelets, plasma factors, and immunoglobin, the rapid development
of blood banks by government and private institutions, and increased awareness
regarding the importance of blood-transfusion related diseases are some of the
key factors propelling the market growth.
Technological advancements in the
immunohematology devices include fully automated analyzers that perform the
blood screening test and deliver speedy & accurate results. The
technological advances have significantly improved the clinical outcomes and
helped increasing reliability and accuracy. Such advancements have enabled the
end-users to adopt a vitro study of blood compatibility between the receiver’s
and donor’s blood. Advanced antiglobulin screening instruments and assays
validate for proper blood typing. Key market players are significantly
investing in Research & Development and product innovation. Furthermore,
the companies are focusing on improving the safety and longevity of blood
stored in blood banks by innovating advanced immunohematology devices.
The upcoming market trend is of
Reagent rentals or leasing analyzers. However, considering that the high costs
of the analyzers and of reagents are reducing the sales of immunohematology
devices, manufacturers are permitting the end-users to rent the advanced
reagents and analyzers. The biggest problems hampering the market growth is the
availability of the truly voluntary altruistic blood donor. Despite, screening
for transfusion transmissible diseases is now widespread although there is
still a scope and requirement to enhance quality assurance procedures and to
improve the outcome. Lack of awareness and shortage of skilled
professionals to carry out the process are some of the major hindrances to the
immunohematology market during the forecast period.
To identify the key trends in
the industry, click on the link below:
No comments:
Post a Comment